Fundamentals of clinical cardiology
Intrauterine virus infections and congenital heart disease James C. Overall, Jr., M.D. Srrlt Lake City, Utah mhe incidence of clinically significant
1.
--congenital heart disease is approximately 5 cases per 1,000 live births.' Thus, about 20,000 babies with congenital heart disease will be born each year in the United States. ~4lthough great strides have been made in the de\-elopment of sophisticated technology-for the diagnosis and surgical correction of these defects, their etiologic basis remains largely undefined. In only about 20 per cent of ma:or congenital defects is the cause known. Approximately 10 per cent are due to environmental causes such as virus infections, drugs, or radiation; the remaining 10 per cent are of genetic origin, resulting from familial inheritance and/or chromosomal aberrations." The majority of congenital heart lesions are probably not the result of genetic or environmental factors acting alone, but rather the result of these factors acting in concert \vith one anotller.3 The genetically predisposed fetus is exposed to the appropriate environmental factor at a particular Ftage during organogenesis which leads fcJ the development of malformat ions.",i
Since genetic control is unlikely to be developed to the point of practical application in the near future, the search for environmental factors would appear to be the most profitable area for current effort. The aim would be, of course, to protect the susceptible host from the specific causative factors. The purpose of this review is to evaluate critically the present understanding of the role of intrauterine virus infections in the production of congenital heart disease. To this end we shall examine the methods utilized in establishing the association between viruses and congenital defects, the pathogenesis of the fetal infection and the mechanism of the production of defects, the currently available information concerning specific viruses whicli are known (rubella) or strongly suspected (Coxsackie B and mumps) etiologic agents in congenital heart disease, and the possibility that other viruses could be causative agents. The most promising areas for future research as well as the prospects for control of virus-induced congenital heart disease will be discussed. In this review "congenital defect" is used to refer to any structural abnormality present at birth which is due either to faulty development during the period of organogenesis or to damage to fetal tissues or organs which have already developed; the phrase "congenital malformation" is a more restricted term referring to an abnormality resulting from faulty organogenesis. The clinical manifestations of the congenital rubella syndrome are well described and include low birth weight due to intrauterine growth retardation, cardiac malformations, cataracts and microphthalmia, mental retardation, hepatosplenomegaly, thrombocytopenic purpura, and lesions in the long t,ones.5 The incidence of congenitally acquired rubella is approximately 1 case per 1,000 live births during nonepidemic periods (pre-rubella vaccine data), but rose to 7 cases per 1,000 births during the 1964 epidemic. The frequency of all malformations is highest when the maternal infection occurs early in pregnancy-a 10 to 50 per cent malformation rate with infection in the first month, a 14 to 25 per cent malformation rate in the second month, and a 7 to 17 per cent malformation rate in the third month.5 Congenital heart disease occurred in 48 per cent of a series of 376 children with rubella syndrome.lg The most common cardiac lesions in 87 catheterized patients were: patent ductus arteriosus in 78 per cent, right pulmonary artery stenosis in 70 per cent, left pulmonary artery stenosis in 56 per cent, valvular pulmonic stenosis in 40 per cent, mild aortic valvular stenosis in 14 per cent, aberrant subclavian artery in 11 per cent, and ventricular septal defect in 10 per cent. It is clear that the majority of cardiac malformations occur when rubella infects the mother during the first trimester, although pulmonary artery stenosis has been reported following rubella infection after the first trimester.20
It has been estimated that maternal rubella may account for between 1 and 2 per cent of all malformations of the heart.'
Rubella is the only viral agent which has been proved to be a true teratogen; that is, which results in congenital mnlformations. Hence, knowledge of the mechanisms by which rubella causes deformities may lead to a more basic understanding of the pathogenesis of congenital malformation of the heart. Rubella is a noncytolytic virus in certain tissues; that is, it does not destroy the cells in which it replicates. This characteristic would tend to allow survival of the infected fetus, yet result in disordered function of cells, tissues, and organs. On the other hand, selective cell destruction may occur. In pathologic studies of therapeutically aborted rubella infected fetuses, scattered foci of necrotic cellular damage without inflammatory infiltrate were noted in endothelial cells of blood vessels and in myocardial cells.8 These rubella-induced defects could result in the defective form and/or function of the developing tissue by direct cellular destruction or hypoxic damage secondary to blood vessel obliteration. Alteration of the elastic or muscle fibers in the ductus arteriosus, for example, could be the reason for the failure of postnatal ductus closure. Studies with tissue obtained from infants with rubella syndrome and maintained in culture revealed that the cells were persistently infected with rubella Overall Am. Heart I. December.
197' 2 virus and had a decreased growth rate and shortened survival time.21 Naeye and Blancz2 noted that the growth retardation in infants with the rubella syndrome was the result of a decreased number of cells in the organs. This impaired cellular growth, if it occurred during a crucial phase in cardiac development, could well result in such cardiac anomalies as septal defects. Increased numbers of chromosome breaks have been noted in leukocyte cultures of children with congenital rubella.23 It is possible that this chromosomal injury results in cell loss (due to impaired DNA replication) during rapid organ development and is in part responsible for the congenital anomalies.
Transplacental infection with rubella \-irus has been demonstrated in the monkey, ferret, rabbit, and rat.' However, the complete rubella syndrome as it occurs in humans, particularly with regard to cardiac defects, has not been duplicated in experimental animals.rJ4 The neonatal rat is the only animal that has shown evidence of cardiac damage following gestational rubella."j Pathologic sections of the involved hearts revealed disrupted cords of cardiac muscle and septa, with scattered eosinophilic areas replacing cardiac tissue. Rubella virus antigen was demonstrated by immunofluorescence techniques in these same areas. There \vas no mention of gross cardiovascular defects.
There are many unanswered questions concerning the pathogenesis of congenital rubella. Why does the virus damage cells of the myocardium, lens, and inner ear in the fetus but not in the adult? Are similar pathogenic mechanisms instrumental in the production of cardiovascular anomalies and in producing damage to the lens? Is the disturbance in organogenesis primarily a matter of cell death or are more subtle derangements in cell function operative? The answers to these questions depend upon an increased understanding of the molecular biology of virus-cell interaction obtained through in vitro studies of human tissue and the use of animal models.
Coxsackie B virus. There is strong circumstantial evidence that the Coxsackie B group of viruses may be etiologically associated with congenital heart disease. These viruses are the most common agents known to C~LW myocarditis and pericarditis in children and adults, thus demonstrating their strong cardiotropic potential.26 Transplacental infection of the late gestation fetus has been reported with disseminated disease presenting in the newborn infant as myocarditis, hepatitis, and meningoencephalitis. Brown and Evans,27 in a prospective study, demonstrated the significant association between serologic evidence of Coxsackie B3 and B4 virus infection in mothers during the first trimester of pregnancy and the birth of infants with various types of congenital heart disease. Approximately half of the maternal infections were completely subclinical; in those cases where symptoms occurred, none would have permitted a specific clinical diagnosis. There was no difference between mothers of infants with congenital abnormalities and matched control mothers of normal infants with regard to the incidence of infection with other Coxsackie virus types Bl, 132, B.5, and A9, with ECHO virus types 6 and 9, with influenza virus types A and B, or with the adenovirus group. There \vas no serologic evidence of rubella in any of the mothers who gave birth to infants with heart anomalies. Virus isolation and antibody studies were not done on the infants. Burch and co-workers28 demonstrated the presence of Coxsackie B virus antigen by immunofluorescence techniques in myocardial tissue obtained at routine autopsies from infants and children. Twenty-nine of 50 hearts exatnined showed interstitial myocarditis; in 12 of these, specific antigen was demonstrated. Five infants in this latter group either were stillborn or died within hours after birth, further documenting the transplacental passage of this group of agents. None of these five infants, however, had evidence of congenital heart disease. In a previous publication by this same group of investigators,2g Coxsackie B antigen was demonstrated in the myocardium of an infant who died at 2 days of age and who had a widely patent ductus arteriosus. Bates30 described a stillborn infant with calcific pancarditis and hydrops fetalis in whose myocardium specific Coxsackie B3 virus antigen was demonstrated. No gross cardiovascular anomaly was noted. In contrast to rubella, no large-scale epidemic has been reported with Coxsackie (1) confirmation by other laboratories of the provocative serologic studies of Brown and Evans27 (2) the demonstration of specific IgNl antibodies in umbilical cord or neonatal sera directed against the Coxsackie B viruses in significant numbers of infants with congenital heart lesions as compared with control infants, (3) the isolation of Coxsackie B viruses from significant numbers of newborn infants with congenital heart disease as compared with the isolation from normal control infants, and (4) the identification of Coxsackie B virus antigen in the myocardium and/or cardiac lesions of a significant number of infants who died with congenital heart disease as compared with infants who died from noncardiac and noninfectious causes.
Munzps. The issue of the relationship between intrauterine mumps virus infection and postnatal endocardial fibroelastosis (EFE) remains controversial.32-35 The clinical evidence supporting this relationship is the occurrence of a significantly higher incidence of skin test positivity to mumps antigen in patients with EFE than in matched controls. However, mumps virus has not been isolated from these patients, and mumps antibody has usually not been present in their serum. For the newborn infant to have a positive skin test without the presence of virus or antibody, the fetus must: (1) recover from the virus infection in utero so that the virus cannot be isolated after birth, and (2) manifest a cellular, but not humoral, immune response against the mumps virus antigen so that delayed hypersensitivity, but not antibody, is demonstrable. It is appropriate to examine the available experimental data concerning the fetal response in order to determine the validity of these hypotheses.
Fetal recovery from intrauterine virus infection has been documented and transplacental passage of maternal antibody may play a role in this recovery process.6 Development of a cellular immune response without a humoral immune response in the fetus could occur by one of several mechanisms: (1) a tolerance could develop with respect to humoral but not cellular immunity, (2) the virus infection could occur at such a time during the ontogeny of the immune response in the fetus that the capacity to express cellular immunity was present but not the ability to produce antibody, and (3) maternal passive antibody could inhibit humoral, but not cellular, immunity. Most experimental evidence would argue against the first two mechanisms.
In the animal models where antibody tolerance to intrauterine virus infection exists, there has been demonstrable persistence of virus in the circulating blood and tissues."s3" As noted, mumps virus has not been isolated from patients with EFE. In most mammalian species where the ontogeny of the immune response has been examined, the capacity to produce antibody develops prior to the ability to reject skin grafts or to manifest skin-test-delayed hypersensitivi ty. 36 The postulated mumps-EFE association requires that delayed hypersensitivity develop prior to antibody production. The inhibition of antibody production by passive antibody administration has been shown to occur3'j; this mechanism therefore remains a possibility.
There Although some prospective studies have shown an increased incidence of abortion and stillbirth following gestational mumps, most have not demonstrated an increase in congenital malforma-Overa Am. Heart J. December. 1972 tions.","J8 In the fen-case reports reviewed by Hyatt3g of congenital abnormalities in infants n-hose mothers had mumps during pregnancy, a variety of types of defects occurred.
Cardiac lesions were infrequent and EFE was not specifically mentioned. There has been little or no evidence that mumps infection occurred during pregnancy in the mothers of infants who developed EFE. 35 However, in support of the mumps virus etiology of EFE, there has been one case report40 of acquired myocarditis and autopsy-proved endocardial fibroelastosis following mumps virus infection in a 19-month-old child. In addition, there are experimental animal data to add to the evidence. Infection of chick embryos with mumps virus during the very early phases of differentiation resulted in persistent virus infection, particularly of the heart and brain, and pathologic evidence of interstitial myocarditis in the late gestation embryo.41 Chicks at one year of age showed evidence of EFE. Antibody was demonstrated by one month of age in the chicks, l)ut delayed hypersensitivity to mumps virus could not be elicited. Direct inoculation of first trimester fetal monkeys with mumps virus resulted in virus replication which was controlled and led to the development of cellular immunity but no detectable humoral immunity in the newborn animals.42 To date, cardiac pathology has not been seen in the infected monkeys. Thus, the chick embryo model provides evidence that gestational mumps can cause EFE and the monkey fetus model suggests that intrauterine mumps can result in cellular, but not humoral immunity in the newborn.
It would appear that there is suggestive evidence that gestational mumps is etiologically related to EFE; however, as noted, there is conflicting evidence. Further studies will be required before the relationship is conclusively proved or disproved. Additional information which would be helpful in establishing the association includes: (1) Intrauterine virus infections and CHD 829 cause congenital heart disease is long. It is not possible to predict which viruses are likely to cause fetal abnormalities from the diseases that these viruses produce in children and adults. Fifty years ago who would have predicted that rubella or cytomegalovirus infections would be significant factors in the genesis of congenital defects? It becomes obvious, then, that the task of identifying specific viruses as etiologic agents in the entire spectrum of congenital heart disease will not be an easy one.
Future efforts
The areas of research which would appear to hold the greatest promise for future investigation fall into one of four categories: (1) the epidemiology of congenital heart disease, (2) the association of maternal viral infection with abnormal offspring, (3) the in-depth virologic investigation of the infant with a cardiac defect, and (4) the development of experimental animal models of congenital heart disease.
More precise epidemiologic surveillance data are needed to determine two aspects of congenital heart disease: (1) the frequency of occurrence of the various types of defects in different populations, and (2) the effect of race, geography, climate, or season of the year on the occurrence of these defects. The correlation between recognized patterns of epidemiology and the pathogenesis of infectious diseases and the occurrence of congenital heart disease will provide leads for the possiI)le association of particular \.iral agents with specific heart lesions and \vill suggest areas for further in-depth stud>,. For example, an association has been reported l)et\\.een seasons of the year and tile I)irtll of children with patent ductus arteriosusL A search for possible causative \.iruses, I)y both epidemiologic and laboratory means, could focus initially on those agents knot\-n to be seasonally prevalent at the time of or shortly after conception in these pregnancies. Other epidemiologic factors such as (1) the frequency of infection in women of childbearing age with the suspected viruses, and (2) the occurrence of viremia as part of the pathogenesis of the disease in the mother can be utilized to narrow the spectrum of \Tiral agents even further.
In the consideration of future efforts to associate specific viral agents with particular constellations of congenital defects, it is appropriate to examine the approaches utilized in the establishment of rubella and cytomegalovirus as causative agents of congenital abnormalities. Although the documentation of maternal infection during pregnancy and the association with abnormal offspring will provide important suggestive information, proof of the association must come from evidence of infection in the abnormal newborn. With all the negative data from previous reports, it is unlikely that clinically recognized \-iral infections during pregnancy are a major cause of congenital malformations. Thus, for the reasons noted above, the most productive information concerning maternal infection will likely come from large prospective studies.
Extensive virus isolation and serologic studies should be attempted in defective neonates where the etiology is not readily apparent. In congenital rubella and cytomegalovirus infections and in virtually all of the animal models of intrauterine virus infections, either virus or antibody or both are demonstrable in the newborn. By focusing on the almormal newborn, the investigator can be more selective in terms of numbers of patients and he can proceed with more in-depth studies. One can question, however, whether the absence of a demonstral~le viral agent or of a specific antibody in the newborn in ant can, in fact, rule out an intrauterine virus infection. The obvious exception would be when the infection is due to a ne\\-viral agent which had not previously been isolated or to a knou-n agent which would not grow in the cell culture systems routinely utilized for virus isolation. The approach to this problem would, of course, be the application of the new, not previously utilized, techniques available for culturing and identifying viral agents. The success of this approach requires that there be a persistent infection in the fetus so that the virus is present in the excretions or tissues of the newborn infant and/or that a fetal humoral immune response occur which results in antibody being present in the neonate.
It is theoretically possible, however, that intrauterine virus infection could occur, but that neither virus nor antibody would 830 Overall Am. Heavt J. December, 1972 be demonstrable in the newborn infant even if techniques appropriate for that virus were utilized.
The experimental data which would support or refute this hypothesis should be examined. A virus could infect the early gestation fetus and result in tissue destruction and/or alteration of organogenesis, yet be eliminated prior to birth. Recovery of the fetus from the infection could occur through the production and action of interferon, of maternal transplacental antibody, or through other nonspecific factors developed by the mother or through processes occurring in her, in the placenta, or in the fetus.6*4g There are good clinical and experimental data to indicate that the fetus may be capable of controlling certain virus infections in utero, but the mechanisms responsible are poorly understood.6s20*43,4g Absence of antibody in the newborn infant, even though there had been exposure to an antigen (virus) in utero, was shown to be possible in the discussion of the mumps-EFE hypothesis. Studies in the fetal lamb have shown that challenge of the immunologically immature fetus with an antigen will not elicit a detectable antibody response. 36,48 Challenge of that same fetus with the same antigen at a later gestational age or after birth at a time when it has developed the capacity to respond immunologically, results in a primary antibody response identical to that which would be expected if the animal had never been exposed to the antigen.
In other words, there was no detectable primary antibody response to the antigen in the early gestation fetus, there was no evidence of a secondary or anamnestic response when the fetus was rechallenged with the same antigen, and there was no evidence of immunologic tolerance to the antigen. Each of these three parameters has been utilized to determine prior exposure to an antigen, yet, as noted, none may be present in the newborn animal which received an antigenie challenge early in gestation.
Further work needs to be done to determine if virus infection of the early gestation fetus can result in a similar situationrecovery from the infection but no humoral evidence of contact with the virus antigen. 'The studies of St. Geme and associates41s42 with mumps virus infection of the fetal monkey are important in this regard. The use of experimental animals will provide the opportunity to determine if viral agents suspected of causing abnormalities in humans can produce defects in animals. In addition, if congenital defects produced in animal models are similar to those found in humans, this would permit the elucidation of mechanisms responsible for the genesis of these defects. Studies should be performed not only with human viruses, but also with viral agents which are natural to that particular animal species. To the writer's knowledge, a good mammalian animal model for congenital heart disease is not available. The microscopic lesions noted in the cardiac muscle of fetal rats infected with rubella virus were mentioned above.*5 Ectopic hearts were occasionally noted in hamster embryos infected Intrauterine virus infections and CHD 531 following intravenous inoculation of the pregnant female with H-l virus.51 The ideal natural virus model infection would be one in which the virus infected the mother, causing little or no disease, was passed transplacentally, and resulted in infection of the fetus with the production of defects.
Much of the work on fetal infection to date has been of a descriptive nature-i.e., which viruses can infect and cross the placenta, which viruses infect and damage the fetus, the time during gestation that maternal infection occurs which then results in fetal infection and disease, and the pathologic nature of the fetal disease. r\4uch remains to be learned about the mechanisms of resistance to virus infection in the fetus and how these mechanisms differ from similar mechanisms in the adult. We need to learn the basis for the enhanced susceptibility of the fetus to virus infection and what the role of the placenta is! not only in preventing or in permitting transmission of virus to the fetus, but also in assisting recovery from infection once the virus has reached the fetus.
Prospects for control
The likelihood of developing effective means of preventing virus-induced congenital heart disease in humans xvi11 depend on the results of the studies on etiology and 011 the pathogenesis of infections in the fetus. If only a few viruses are identified as causative agents, then the production of \~~ccines for immunization I\-ould I)e a feasil)le goal. The development of rubella vnccinc is a good example of successful efforts in this area. However, the mere identification of a teratogenic agent does not mean that successful vaccine production will ensue. For example, the prospects for a cytomegalovirus vaccine do not appear bright. If the number of causative agents is large, vaccine production would not be a practical solution and antiviral chemotherapy would provide an alternate approach. Rapid and efficient means would have to be developed to provide an accurate etiologic diagnosis of virus infections during the early gestational period in the woman. Once infection with a teratogenic agent was identified, safe and effective antiviral drugs would be needed for treatment of the infection in the mother and in the fetus. A great deal of work has been done and is currently in progress on the use of interferons2 and interferon inducer9 in the treatment of human viral disease. Certainly further work is necessary to check the efficacy of these substances in experimental animals with a number of different types of virus infections before their use in human viral disease can be expected. However, limited clinical trials have been cautiousiy undertaken. As will be obvious, both the vaccine and the antiviral chemotherapeutic approach to the prevention and/or control of congenital heart disease is still a dream of the future. It is only through the persistent and combined efforts of both clinical and laboratory research that sufficient information will become available to allow attempts to be made toward practical solutions of the problem.
Summary
The etiologic basis for the vast majorit!. of cases of congenital heart disease remains largely undefined. Viruses have been considered to he likely candidates since the recognition of the association between intrauterine rubella and congenital heart disease. Although the pathogenesis of cardiovascular defects is poorly understood, information gained from the study of congenital rubella syndrome suggests that mechanisms sucll as focal endothelial cell damage, resulting in obliteration of \XSCU-lar suppl>-, decreased growth rate, and shortened survival titnc of certain cells, and disturbed DNA replication in cells n,hose chromosomes were damaged secondary lo the effects of virus replication may IX operative in the production of defects in the developing fetus. In addition to rubella there is suggestive, but not conclusive, evidence that Coxsackie B3 and B4 virus infections during pregnancy can result in the birth of infants with a variety of types of congenital heart lesions and that intrauterine mumps virus infection may be etiologically related to the postnatal development of endocardial fibroelastosis (EFE) . Although there are a number of other viruses that are potential etiologic agents of congenital heart disease, the current status of information is inadequate to allow even suggestive associations to be made. The most profitable areas for future inves-
